2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
2
Breast Neoplasms
2
Pancreatic Neoplasms
1
Non-alcoholic Fatty Liver Disease
1
Lung Neoplasms
1
Insulin Resistance
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Metformin
30
Exercise
8
Pioglitazone
7
Inositol
6
Insulin
5
Acupuncture Therapy
4
High-Intensity Interval Training
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
drospirenone and ethinyl estradiol combination
2
Water
2
Tablets
2
Surveys and Questionnaires
2
Sugars
2
Resistance Training
2
Preoperative Exercise
2
Observation
2
Folic Acid
2
Diet Therapy
2
Cyproterone Acetate
2
Cholecalciferol
2
Caloric Restriction
2
Biguanides
2
ziprasidone
1
maltodextrin
1
lime
1
licogliflozin
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Insulin Resistance
×
Canagliflozin
×
Clear all
NCT04700839
2022-09-10
PCOS
Shanghai 10th People's Hospital
Phase 4
Completed
68 enrolled